Nathaniel Simons
Meritage Group
Nathaniel Simons Merck & Company Inc stake
total: 301
Meritage Group MRK trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2023 Q4
- Held for:
- 3 quarters
- Latest activity:
- 2024 Q3
According to 2026 Q2 report, Nathaniel Simons doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $109.72 for "buy" trades and estimated average "sell" price is $125.74. Meritage Group first purchased MRK in 2023 Q4, initially acquiring 2,873 shares. Since the initial investment in Merck & Company Inc (MRK), Meritage Group has made 3 more transactions.
When did Nathaniel Simons sell Merck & Company Inc (MRK)?
Nathaniel Simons sold off the entire Merck & Company Inc (MRK) position in 2024 Q3.
When did Nathaniel Simons buy Merck & Company Inc (MRK)?
Nathaniel Simons first invested in Merck & Company Inc (MRK) in 2023 Q4 at the reported quarter-end price of $108.95 per share.
What's the cost basis of Meritage Group's MRK stake?
The estimated cost basis for Merck & Company Inc (MRK) stake is around $109.72 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $109.72
- Weighted AVG sell price:
- $125.74
Nathaniel Simons's historical trades in Merck & Company Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q3
|
0.00%
|
0
|
$123.80
|
|
-100% (-2,292)
|
-0.01%
|
|
2024 Q2
|
0.01%
|
2,292
|
$123.80
|
$283,750
|
+7.45% (+159)
|
+0%
|
|
2024 Q1
|
0.01%
|
2,133
|
$131.74
|
$281,000
|
-25.76% (-740)
|
-0%
|
|
2023 Q4
|
0.01%
|
2,873
|
$108.95
|
$313,000
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.